BIT 2.70% 3.8¢ biotron limited

Guys, A10 day monotherapjy was never going to produce...

  1. 772 Posts.
    lightbulb Created with Sketch. 139
    Guys,

    A10 day monotherapjy was never going to produce spectacular results.

    That was not the intention.

    Safety and proving antiviral activity was the aim.

    Moving forward, with a prsxumed license to administer bit225 for 3 months in a capsule, does gilead or any other pharma see an opportunity to partner up In their future trials.

    I bet yes as this may be the missing link in a HIV cur by targeting the re-infection cells that current drugs cannot.

 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.8¢
Change
0.001(2.70%)
Mkt cap ! $34.28M
Open High Low Value Volume
3.7¢ 4.0¢ 3.7¢ $68.85K 1.794M

Buyers (Bids)

No. Vol. Price($)
2 150000 3.7¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 349950 3
View Market Depth
Last trade - 15.10pm 28/06/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.